ALBO logo

Albireo Pharma (ALBO) EBIT

Annual EBIT

-$20.10 M
+$76.17 M+79.12%

December 31, 2021

Summary

Performance

1-Year Change

+79.12%

3-Year Change

+51.28%

5-Year Change

+18.22%

15-Year Change

+18.22%

ALBO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$774.00 K

3-Year Low

-$20.10 M
ALBO annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
ALBO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
ALBO next annual earnings announcement has not yet been scheduled

OtherALBOprofitabilitymetrics:

Annual Revenue

$40.58 M
ALBO annual revenue is $40.58 million

Annual Net Income

-$34.03 M
ALBO annual net profit is -$34.03 million

Annual EBITDA

-$19.82 M
ALBO annual EBITDA is -$19.82 million

Annual EPS

-$1.77
ALBO annual earnings per share is -$1.77

Quarterly EBIT

-$35.27 M
+$1.93 M+5.20%

September 30, 2022

Summary

Performance

3-Month Change

+5.2%

1-Year Change

-154.93%

3-Year Change

-70.91%

5-Year Change

-439.79%

ALBO Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$64.21 M
ALBO quarterly earnings before interest & taxes is currently -154.93% below its historical high of $64.21 million

3-Year Low

-$39.56 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
ALBO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
ALBO next earnings announcement has not yet been scheduled

OtherALBOprofitabilitymetrics:

Quarterly Revenue

$9.83 M
ALBO quarterly revenue is $9.83 million

Quarterly Net Income

-$37.80 M
ALBO quarterly net profit is -$37.80 million

Quarterly EBITDA

-$35.15 M
ALBO quarterly EBITDA is -$35.15 million

Quarterly EPS

-$1.92
ALBO quarterly earnings per share is -$1.92

TTM EBIT

-$123.53 M
-$99.48 M-413.64%

September 30, 2022

Summary

Performance

3-Month Change

-413.64%

1-Year Change

-311.67%

3-Year Change

-115.12%

5-Year Change

-115.12%

ALBO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$846.00 K

3-Year Low

-$123.53 M
ALBO TTM earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
ALBO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
ALBO next earnings announcement has not yet been scheduled

OtherALBOprofitabilitymetrics:

TTM Revenue

$57.39 M
ALBO TTM revenue is $57.39 million

TTM Net Income

-$131.15 M
ALBO TTM net profit is -$131.15 million

TTM EBITDA

-$123.10 M
ALBO TTM EBITDA is -$123.10 million

TTM EPS

-$6.72
ALBO TTM earnings per share is -$6.72

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$20.10 M
ALBO annual earnings before interest & taxes is -$20.10 million

Annual Revenue

$40.58 M
ALBO annual revenue is $40.58 million

Annual Cost Of Goods Sold

$1.36 M
ALBO annual cost of goods sold is $1.36 million

Annual Operating Expenses

$162.71 M
ALBO annual total operating expenses is $162.71 million

ALBO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+79.1%-154.9%-311.7%
3 y3 years+51.3%-70.9%-115.1%
5 y5 years+18.2%-439.8%-115.1%

ALBO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+206.9%+12.2%+521.4%at low
5 y5-yearat high+379.0%-154.9%+12.8%+521.4%at low
alltimeall time+2496.6%+379.0%-154.9%+12.8%>+9999.0%at low

Albireo Pharma EBIT History

DateAnnualQuarterlyTTM
Sep 2022
-
-$35.27 M(-5.2%)
-$123.53 M(+413.6%)
Jun 2022
-
-$37.20 M(-6.0%)
-$24.05 M(+21.0%)
Mar 2022
-
-$39.56 M(+244.2%)
-$19.88 M(-1.1%)
Dec 2021
-$20.10 M(-79.1%)
-$11.49 M(-117.9%)
-$20.10 M(-33.0%)
Sep 2021
-
$64.21 M(-294.4%)
-$30.01 M(-75.3%)
Jun 2021
-
-$33.03 M(-17.0%)
-$121.32 M(+13.9%)
Mar 2021
-
-$39.78 M(+85.9%)
-$106.50 M(+10.6%)
Dec 2020
-$96.27 M(+67.7%)
-$21.40 M(-21.0%)
-$96.27 M(+18.8%)
Sep 2020
-
-$27.10 M(+48.8%)
-$81.03 M(+8.7%)
Jun 2020
-
-$18.21 M(-38.4%)
-$74.56 M(+4.1%)
Mar 2020
-
-$29.55 M(+379.7%)
-$71.62 M(+24.7%)
Dec 2019
-$57.42 M(+39.2%)
-$6.16 M(-70.1%)
-$57.42 M(-13.4%)
Sep 2019
-
-$20.64 M(+35.1%)
-$66.32 M(+13.7%)
Jun 2019
-
-$15.28 M(-0.5%)
-$58.34 M(+4.2%)
Mar 2019
-
-$15.35 M(+1.9%)
-$56.00 M(+35.8%)
Dec 2018
-$41.25 M(+67.9%)
-$15.05 M(+18.9%)
-$41.23 M(+30.8%)
Sep 2018
-
-$12.66 M(-2.2%)
-$31.51 M(+24.1%)
Jun 2018
-
-$12.94 M(+2126.7%)
-$25.39 M(+33.2%)
Mar 2018
-
-$581.00 K(-89.1%)
-$19.06 M(-22.4%)
Dec 2017
-$24.58 M(+99.9%)
-$5.34 M(-18.3%)
-$24.58 M(+27.7%)
Sep 2017
-
-$6.53 M(-1.1%)
-$19.24 M(+34.8%)
Jun 2017
-
-$6.61 M(+8.4%)
-$14.27 M(+32.6%)
Mar 2017
-
-$6.10 M(+289.6%)
-$10.76 M(-23.0%)
Dec 2016
-$12.29 M(-12.0%)
-
-
Sep 2016
-
-$1.56 M(-49.5%)
-$13.97 M(-11.7%)
Sep 2016
-$13.97 M(-29.3%)
-
-
Jun 2016
-
-$3.10 M(-49.0%)
-$15.83 M(-18.0%)
Mar 2016
-
-$6.08 M(+88.5%)
-$19.30 M(+8.7%)
Dec 2015
-
-$3.23 M(-5.7%)
-$17.75 M(-10.2%)
Sep 2015
-$19.77 M(+2.6%)
-$3.42 M(-48.0%)
-$19.77 M(-1.4%)
Jun 2015
-
-$6.58 M(+45.3%)
-$20.04 M(+10.1%)
Mar 2015
-
-$4.53 M(-13.6%)
-$18.21 M(-6.4%)
Dec 2014
-
-$5.24 M(+42.0%)
-$19.46 M(+1.0%)
Sep 2014
-$19.26 M(-6.5%)
-$3.69 M(-22.3%)
-$19.26 M(-3.3%)
Jun 2014
-
-$4.75 M(-17.9%)
-$19.93 M(-2.3%)
Mar 2014
-
-$5.78 M(+14.7%)
-$20.39 M(+2.9%)
Dec 2013
-
-$5.04 M(+15.7%)
-$19.83 M(+7.5%)
DateAnnualQuarterlyTTM
Sep 2013
-$20.59 M(-0.7%)
-$4.36 M(-16.5%)
-$18.45 M(-7.5%)
Jun 2013
-
-$5.22 M(+0.0%)
-$19.95 M(-4.1%)
Mar 2013
-
-$5.21 M(+42.3%)
-$20.80 M(+4.5%)
Dec 2012
-
-$3.67 M(-37.4%)
-$19.90 M(-3.4%)
Sep 2012
-$20.73 M(+96.5%)
-$5.85 M(-3.6%)
-$20.61 M(+94.2%)
Jun 2012
-
-$6.07 M(+40.9%)
-$10.61 M(+25.0%)
Mar 2012
-
-$4.31 M(-1.4%)
-$8.49 M(-11.7%)
Dec 2011
-
-$4.37 M(-205.6%)
-$9.62 M(-8.8%)
Sep 2011
-$10.55 M(-72.5%)
$4.14 M(-204.9%)
-$10.55 M(-53.9%)
Jun 2011
-
-$3.95 M(-27.4%)
-$22.86 M(-17.1%)
Mar 2011
-
-$5.44 M(+2.5%)
-$27.58 M(-15.2%)
Dec 2010
-
-$5.30 M(-35.1%)
-$32.53 M(-15.3%)
Sep 2010
-$38.39 M(-10.6%)
-$8.17 M(-5.7%)
-$38.40 M(-5.7%)
Jun 2010
-
-$8.67 M(-16.6%)
-$40.73 M(-4.6%)
Mar 2010
-
-$10.39 M(-7.0%)
-$42.70 M(-3.0%)
Dec 2009
-
-$11.17 M(+6.2%)
-$44.02 M(+2.5%)
Sep 2009
-$42.93 M(-9.3%)
-$10.51 M(-1.1%)
-$42.93 M(-7.5%)
Jun 2009
-
-$10.63 M(-9.3%)
-$46.41 M(-0.9%)
Mar 2009
-
-$11.72 M(+16.3%)
-$46.83 M(+2.4%)
Dec 2008
-
-$10.07 M(-28.0%)
-$45.75 M(-3.4%)
Sep 2008
-$47.35 M(+94.7%)
-$13.99 M(+26.7%)
-$47.35 M(+6.8%)
Jun 2008
-
-$11.04 M(+3.8%)
-$44.33 M(+18.3%)
Mar 2008
-
-$10.64 M(-8.9%)
-$37.48 M(+16.5%)
Dec 2007
-
-$11.68 M(+6.4%)
-$32.16 M(+32.1%)
Sep 2007
-$24.32 M(+222.8%)
-$10.97 M(+161.3%)
-$24.35 M(+55.2%)
Jun 2007
-
-$4.20 M(-21.1%)
-$15.68 M(+13.7%)
Mar 2007
-
-$5.32 M(+37.9%)
-$13.79 M(+28.0%)
Dec 2006
-
-$3.86 M(+67.3%)
-$10.78 M(+33.5%)
Sep 2006
-$7.54 M(+122.3%)
-$2.31 M(0.0%)
-$8.07 M(+22.1%)
Jun 2006
-
-$2.31 M(0.0%)
-$6.61 M(+28.4%)
Mar 2006
-
-$2.31 M(+100.3%)
-$5.15 M(+39.6%)
Dec 2005
-
-$1.15 M(+36.1%)
-$3.69 M(+9.0%)
Sep 2005
-$3.39 M(+338.0%)
-$846.00 K(0.0%)
-$3.38 M(+33.3%)
Jun 2005
-
-$846.00 K(0.0%)
-$2.54 M(+50.0%)
Mar 2005
-
-$846.00 K(0.0%)
-$1.69 M(+100.0%)
Dec 2004
-
-$846.00 K
-$846.00 K
Sep 2004
-$774.00 K
-
-

FAQ

  • What is Albireo Pharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Albireo Pharma?
  • What is Albireo Pharma annual EBIT year-on-year change?
  • What is Albireo Pharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Albireo Pharma?
  • What is Albireo Pharma quarterly EBIT year-on-year change?
  • What is Albireo Pharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Albireo Pharma?
  • What is Albireo Pharma TTM EBIT year-on-year change?

What is Albireo Pharma annual earnings before interest & taxes?

The current annual EBIT of ALBO is -$20.10 M

What is the all time high annual EBIT for Albireo Pharma?

Albireo Pharma all-time high annual earnings before interest & taxes is -$774.00 K

What is Albireo Pharma annual EBIT year-on-year change?

Over the past year, ALBO annual earnings before interest & taxes has changed by +$76.17 M (+79.12%)

What is Albireo Pharma quarterly earnings before interest & taxes?

The current quarterly EBIT of ALBO is -$35.27 M

What is the all time high quarterly EBIT for Albireo Pharma?

Albireo Pharma all-time high quarterly earnings before interest & taxes is $64.21 M

What is Albireo Pharma quarterly EBIT year-on-year change?

Over the past year, ALBO quarterly earnings before interest & taxes has changed by -$99.48 M (-154.93%)

What is Albireo Pharma TTM earnings before interest & taxes?

The current TTM EBIT of ALBO is -$123.53 M

What is the all time high TTM EBIT for Albireo Pharma?

Albireo Pharma all-time high TTM earnings before interest & taxes is -$846.00 K

What is Albireo Pharma TTM EBIT year-on-year change?

Over the past year, ALBO TTM earnings before interest & taxes has changed by -$93.52 M (-311.67%)